Multi-investigator Seed Grants – Genomics & Immunology

Click to Apply

The Center for Immunology and the Genome Biology Task Force are excited to call for multi-investigator $50,000 seed grant applications for work at the intersection of genomics & immunology.

Technological advances in functional genomics, particularly at the single cell level, are rapidly improving our ability to decipher the complexities of disease and immunity to identify causal gene networks and cellular mechanisms. Continued discovery increasingly requires interdisciplinary collaboration between research groups with expertise in gene regulation, transcriptomics and epigenomics, computation, and those focused on immune function in vertebrates, insects, and plants.

The Center seeks to support innovative multi-investigator projects that will bring together researchers in the fields of genomics and immunology to tackle important questions and develop novel technologies to fuel discovery. Projects can be genomics-based with an immunology application or immunology-focused with a genomics component. Successful applications are expected to position the investigators competitively for external funding.

Applications are solicited from groups of at least two independent research programs, aiming to submit collaborative grants (standard NSF, NIH multi-PI R01, P01, DOD CDMRP, or similar) within two years of receiving pilot project funding. Applicants may request a maximum of $50,000 for the duration of one year and must meet Cornell’s eligibility requirements to serve as principal investigator on sponsored projects. Funds are restricted to research expenses, core facility charges, and non-faculty personnel; they cannot be used to support travel, faculty salary, or equipment purchases. While investigators from Weill Cornell cannot serve as PIs for this seed grant mechanism, collaboration among faculty across our campuses is encouraged. Grants will be awarded using funds provided by The Center for Immunology and the Vice President for Research and Innovation.

Letter of Intent (LOI) – Due June 6, 2022

LOIs should describe the objectives, approach, and significance of the proposed project and the new collaborative efforts of the investigators involved. It is critical that research ideas are expressed in such a way that a non-expert can understand the ideas and appreciate their significance and potential impact.

Full Application – Due July 25, 2022

Full applications must be uploaded as a single PDF and should include the following:

  • Cover page (1-page maximum), including
    • the name and contact information of the Principal Investigator and co-PI(s)
    • the project title
    • an abstract of up to 250 words that is appropriate to share in the public domain.
  • Research Plan (3-page maximum), including:
    • Specific objectives of the collaborative proposal
    • Significance and Innovation
    • Preliminary data
    • Experimental design

Be sure to draw a clear connection between the objectives and the relevance to the cited extramural funding opportunity within this section.

  • Budget (1-page maximum)
  • A biosketch for all PIs. Please also include a current and pending for all PIs, if not included within biosketch.

There are no formatting guidelines or requirements.

Evaluation Criteria

A review panel will review applications and will advance, and award applications based on scientific merit and the potential to support future extramural funding.


$50,000 for one year


RFA Re-Release: May 3, 2022
Letter of Intent (LOI) Deadline*: June 6, 2022
Full Application Deadline: July 25, 2022
Notice of Award: August 2022
Funding Term: September 1, 2022-August 31, 2023
*Submission and approval of an LOI is required to submit a full application


Deb Fowell or Molly Towne